1504 related articles for article (PubMed ID: 28639165)
41. The Gastrointestinal Load of Carbapenem-Resistant Enterobacteriacea Is Associated With the Transition From Colonization to Infection by
Migliorini LB; Leaden L; de Sales RO; Correa NP; Marins MM; Koga PCM; Toniolo ADR; de Menezes FG; Martino MDV; Mingorance J; Severino P
Front Cell Infect Microbiol; 2022; 12():928578. PubMed ID: 35865821
[TBL] [Abstract][Full Text] [Related]
42. Spread of NDM-5 and OXA-181 Carbapenemase-Producing Escherichia coli in Chad.
Ouchar Mahamat O; Lounnas M; Hide M; Tidjani A; Benavides J; Diack A; Somasse C; Gamougam K; Carrière C; Decré D; Bañuls AL; Jean-Pierre H; Dumont Y; Compain F; Godreuil S
Antimicrob Agents Chemother; 2019 Nov; 63(11):. PubMed ID: 31405861
[TBL] [Abstract][Full Text] [Related]
43. Genotypic Distribution and Antimicrobial Susceptibilities of Carbapenemase-Producing
Jeong S; Lee N; Park MJ; Jeon K; Kim HS; Kim HS; Kim JS; Song W
Ann Lab Med; 2022 Jan; 42(1):36-46. PubMed ID: 34374347
[TBL] [Abstract][Full Text] [Related]
44. A single-day point-prevalence study of faecal carriers in long-term care hospitals in Madrid (Spain) depicts a complex clonal and polyclonal dissemination of carbapenemase-producing Enterobacteriaceae.
Ruiz-Garbajosa P; Hernández-García M; Beatobe L; Tato M; Méndez MI; Grandal M; Aranzábal L; Alonso S; Lópaz MÁ; Astray J; Cantón R
J Antimicrob Chemother; 2016 Feb; 71(2):348-52. PubMed ID: 26518051
[TBL] [Abstract][Full Text] [Related]
45. Emergence of pandrug-resistant carbapenemase-producing
Tartor YH; Ammar AM; Abdelkhalek A; Hassan KA; Shaker A; Elnahriry SS; Nekouei O; Elsohaby I
Front Cell Infect Microbiol; 2024; 14():1318585. PubMed ID: 38562962
[TBL] [Abstract][Full Text] [Related]
46. Phenotypic and genotypic characteristics of carbapenem-resistant Enterobacteriaceae in a tertiary-level reference hospital in Turkey.
Baran I; Aksu N
Ann Clin Microbiol Antimicrob; 2016 Apr; 15():20. PubMed ID: 27048322
[TBL] [Abstract][Full Text] [Related]
47. Genomic characterization of an emerging bla
Kerdsin A; Deekae S; Chayangsu S; Hatrongjit R; Chopjitt P; Takeuchi D; Akeda Y; Tomono K; Hamada S
Sci Rep; 2019 Dec; 9(1):18521. PubMed ID: 31811215
[TBL] [Abstract][Full Text] [Related]
48. [Investigation of carbapenemases in carbapenem-resistant Escherichia coli and Klebsiella pneumoniae strains isolated in 2014 in Turkey].
Çakar A; Akyön Y; Gür D; Karatuna O; Öğünç D; Özhak Baysan B; Çöplü N; Çağatay M; Kılıç A; Baysallar M; Bakıcı Z; Çelik C; Gülay Z; Aydemir Ş; Tünger A; Kılıç H; Erçal BD; Aşçı Toraman Z; Zer Y; Büyüktaş A; Ay S; Aktaş Z; Kayacan Ç; Bayramoğlu G; Aydın F; Dündar D; Hasdemir U; Ayaş R; Yanık K; Günaydın M; Güdücüoğlu H; Parlak M
Mikrobiyol Bul; 2016 Jan; 50(1):21-33. PubMed ID: 27058326
[TBL] [Abstract][Full Text] [Related]
49. Prevalence study on carbapenemase-producing Escherichia coli and Klebsiella pneumoniae isolates in Czech hospitals--results from Czech Part of European Survey on Carbapenemase--Producing Enterobacteriaceae (EuSCAPE).
Hrabák J; Študentová V; Jakubů V; Adámková V; Dvořáková L; Balejova M; Bergerová T; Chmelařová E; Ježek P; Kabelíková P; Kolář M; Paterová P; Tejkalová R; Papagiannitsis C; Žemličková H
Epidemiol Mikrobiol Imunol; 2015 Jun; 64(2):87-91. PubMed ID: 26099612
[TBL] [Abstract][Full Text] [Related]
50. Genetic Relatedness of NDM-Producing
Flores C; Bianco K; de Filippis I; Clementino MM; Romão CMCPA
Microb Drug Resist; 2020 Oct; 26(10):1219-1226. PubMed ID: 32283041
[No Abstract] [Full Text] [Related]
51. Carbapenem-resistant hypermucoviscous
Wang Q; Chen M; Ou Q; Zheng L; Chen X; Mao G; Fang J; Jin D; Tang X
Front Cell Infect Microbiol; 2022; 12():1083009. PubMed ID: 36619764
[TBL] [Abstract][Full Text] [Related]
52. Investigation of Carbapenem resistance mechanisms in Klebsiella pneumoniae by using phenotypic tests and a molecular assay.
Ciftci E; Sesli Cetin E; Us E; Haydar Kutlu H; Cicioglu Arıdogan B
J Infect Dev Ctries; 2019 Nov; 13(11):992-1000. PubMed ID: 32087071
[TBL] [Abstract][Full Text] [Related]
53. Carbapenem resistance in
Jaggi N; Chatterjee N; Singh V; Giri SK; Dwivedi P; Panwar R; Sharma AP
Acta Microbiol Immunol Hung; 2019 Sep; 66(3):367-376. PubMed ID: 31438725
[TBL] [Abstract][Full Text] [Related]
54. Detection of blaIMP4 and blaNDM1 harboring Klebsiella pneumoniae isolates in a university hospital in Malaysia.
Hamzan NI; Yean CY; Rahman RA; Hasan H; Rahman ZA
Emerg Health Threats J; 2015; 8():26011. PubMed ID: 25765342
[TBL] [Abstract][Full Text] [Related]
55. Clinical and Molecular Epidemiology of Carbapenem-Resistant Enterobacteriaceae Among Adult Inpatients in Singapore.
Marimuthu K; Venkatachalam I; Khong WX; Koh TH; Cherng BPZ; Van La M; De PP; Krishnan PU; Tan TY; Choon RFK; Pada SK; Lam CW; Ooi ST; Deepak RN; Smitasin N; Tan EL; Lee JJ; Kurup A; Young B; Sim NTW; Thoon KC; Fisher D; Ling ML; Peng BAS; Teo YY; Hsu LY; Lin RTP; Ong RT; Teo J; Ng OT;
Clin Infect Dis; 2017 May; 64(suppl_2):S68-S75. PubMed ID: 28475792
[TBL] [Abstract][Full Text] [Related]
56. Enterobacterial infection in Saudi Arabia: First record of Klebsiella pneumoniae with triple carbapenemase genes resistance.
Khan MA; Mohamed AM; Faiz A; Ahmad J
J Infect Dev Ctries; 2019 Apr; 13(4):334-341. PubMed ID: 32045378
[TBL] [Abstract][Full Text] [Related]
57. The spread of bla OXA-48 and bla OXA-244 carbapenemase genes among Klebsiella pneumoniae, Proteus mirabilis and Enterobacter spp. isolated in Moscow, Russia.
Fursova NK; Astashkin EI; Knyazeva AI; Kartsev NN; Leonova ES; Ershova ON; Alexandrova IA; Kurdyumova NV; Sazikina SY; Volozhantsev NV; Svetoch EA; Dyatlov IA
Ann Clin Microbiol Antimicrob; 2015 Nov; 14():46. PubMed ID: 26526183
[TBL] [Abstract][Full Text] [Related]
58. In vitro activity of meropenem/vaborbactam and characterisation of carbapenem resistance mechanisms among carbapenem-resistant Enterobacteriaceae from the 2015 meropenem/vaborbactam surveillance programme.
Pfaller MA; Huband MD; Mendes RE; Flamm RK; Castanheira M
Int J Antimicrob Agents; 2018 Aug; 52(2):144-150. PubMed ID: 29510189
[TBL] [Abstract][Full Text] [Related]
59. Clonal emergence of Klebsiella pneumoniae ST14 co-producing OXA-48-type and NDM carbapenemases with high rate of colistin resistance in Dubai, United Arab Emirates.
Moubareck CA; Mouftah SF; Pál T; Ghazawi A; Halat DH; Nabi A; AlSharhan MA; AlDeesi ZO; Peters CC; Celiloglu H; Sannegowda M; Sarkis DK; Sonnevend Á
Int J Antimicrob Agents; 2018 Jul; 52(1):90-95. PubMed ID: 29530587
[TBL] [Abstract][Full Text] [Related]
60. Emergence of carbapenemase-producing Gram-negative bacteria in Saint Petersburg, Russia.
Ageevets VA; Partina IV; Lisitsyna ES; Ilina EN; Lobzin YV; Shlyapnikov SA; Sidorenko SV
Int J Antimicrob Agents; 2014 Aug; 44(2):152-5. PubMed ID: 25059447
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
